Publications in collaboration with researchers from Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (12)

2025

  1. Infectious disease risk after the October 2024 flash flood in Valencia, Spain: Disaster evolution, strategic scenario analysis, and extrapolative baseline for a One Health assessment

    One Health, Vol. 21

  2. Mechanism Insight of Cell Death Signaling by Thymol Derivatives on Trypanosomatidae Protozoan Parasites

    Antibiotics, Vol. 14, Núm. 4

  3. Repurposing COVID-19 Compounds (via MMV COVID Box): Almitrine and Bortezomib Induce Programmed Cell Death in Trypanosoma cruzi

    Pathogens, Vol. 14, Núm. 2

2024

  1. Acrylonitrile derivatives: In vitro activity and mechanism of cell death induction against Trypanosoma cruzi and Leishmania amazonensis

    International Journal for Parasitology: Drugs and Drug Resistance, Vol. 24

  2. Anti-COVID Drugs (MMV COVID Box) as Leishmanicidal Agents: Unveiling New Therapeutic Horizons

    Pharmaceuticals, Vol. 17, Núm. 3

  3. Global Health Priority Box: Discovering Flucofuron as a Promising Antikinetoplastid Compound

    Pharmaceuticals, Vol. 17, Núm. 5

  4. Salvadoran Celastraceae Species as a Source of Antikinetoplastid Quinonemethide Triterpenoids

    Plants, Vol. 13, Núm. 3

  5. Staurosporine as a Potential Treatment for Acanthamoeba Keratitis Using Mouse Cornea as an Ex Vivo Model

    Marine Drugs, Vol. 22, Núm. 9

2023

  1. In vitro activity and mechanism of cell death induction of cyanomethyl vinyl ethers derivatives against Trypanosoma cruzi

    International Journal for Parasitology: Drugs and Drug Resistance, Vol. 22, pp. 72-80

  2. Laurequinone, a Lead Compound against Leishmania

    Marine Drugs, Vol. 21, Núm. 6

  3. Withaferin A-silyl ether analogs as potential anti-kinetoplastid agents targeting the programmed cell death

    Biomedicine and Pharmacotherapy, Vol. 157

2022

  1. Ozone treatment effectively eliminates SARSCoV-2 from infected face masks

    PLoS ONE, Vol. 17, Núm. 7 July